PL2978416T3 - Formulacja farmaceutyczna zawierająca fosfatydylocholinę do leczenia wrzodziejącego zapalenia jelita grubego - Google Patents
Formulacja farmaceutyczna zawierająca fosfatydylocholinę do leczenia wrzodziejącego zapalenia jelita grubegoInfo
- Publication number
- PL2978416T3 PL2978416T3 PL14713808T PL14713808T PL2978416T3 PL 2978416 T3 PL2978416 T3 PL 2978416T3 PL 14713808 T PL14713808 T PL 14713808T PL 14713808 T PL14713808 T PL 14713808T PL 2978416 T3 PL2978416 T3 PL 2978416T3
- Authority
- PL
- Poland
- Prior art keywords
- phosphatidylcholine
- treatment
- pharmaceutical formulation
- ulcerative colitis
- ulcerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13161089 | 2013-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2978416T3 true PL2978416T3 (pl) | 2017-03-31 |
Family
ID=47913311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14713808T PL2978416T3 (pl) | 2013-03-26 | 2014-03-25 | Formulacja farmaceutyczna zawierająca fosfatydylocholinę do leczenia wrzodziejącego zapalenia jelita grubego |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20160045523A1 (pl) |
| EP (1) | EP2978416B1 (pl) |
| JP (1) | JP6262843B2 (pl) |
| KR (1) | KR20150132841A (pl) |
| CN (1) | CN105377247B (pl) |
| AU (1) | AU2014243102B2 (pl) |
| BR (1) | BR112015023849A2 (pl) |
| CA (1) | CA2907401A1 (pl) |
| CL (1) | CL2015002832A1 (pl) |
| DK (1) | DK2978416T3 (pl) |
| EA (1) | EA029514B1 (pl) |
| ES (1) | ES2605650T3 (pl) |
| HK (1) | HK1217089A1 (pl) |
| HU (1) | HUE030707T2 (pl) |
| IL (1) | IL241019A0 (pl) |
| LT (1) | LT2978416T (pl) |
| MD (1) | MD20150089A2 (pl) |
| MX (1) | MX2015013511A (pl) |
| PE (1) | PE20160037A1 (pl) |
| PH (1) | PH12015502199A1 (pl) |
| PL (1) | PL2978416T3 (pl) |
| PT (1) | PT2978416T (pl) |
| SG (1) | SG11201507777TA (pl) |
| UA (1) | UA115585C2 (pl) |
| WO (1) | WO2014154683A1 (pl) |
| ZA (1) | ZA201507910B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5715070B2 (ja) | 2009-02-16 | 2015-05-07 | ノグラ ファーマ リミテッド | アルキルアミド化合物およびその使用 |
| JP6301844B2 (ja) | 2012-02-09 | 2018-03-28 | ノグラ ファーマ リミテッド | 線維症の処置方法 |
| US20190046490A1 (en) * | 2016-02-26 | 2019-02-14 | Nogra Pharma Limited | Methods of treating lactose intolerance |
| BR112021015609A2 (pt) | 2019-02-08 | 2021-10-05 | Nogra Pharma Limited | Processo de fabricação de ácido 3-(4?-aminofenil)-2-metoxipropiônico, e análogos e intermediários do mesmo |
| US20220162238A1 (en) * | 2019-03-05 | 2022-05-26 | Sichuan Gowell Pharmaceutical Co., Ltd. | Fatty acid composition and application thereof |
| CN113368118B (zh) * | 2021-07-21 | 2022-09-23 | 中国药科大学 | 磷脂酰胆碱在制备治疗溃疡性结肠炎的药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3022136C2 (de) * | 1980-06-13 | 1986-07-17 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren zum Abfüllen von Phospholipide enthaltenden pharmazeutischen Massen in Hartkapseln |
| US4560655A (en) * | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| IT1243981B (it) * | 1990-10-01 | 1994-06-28 | Fidia Spa | Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina |
| US5453523A (en) * | 1993-06-16 | 1995-09-26 | Emulsion Technology, Inc. | Process for obtaining highly purified phosphatidylcholine |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| DK1105141T3 (da) * | 1998-08-06 | 2004-03-08 | Wolfgang Stremmel | Phosphatidylcholin som et medikament med slimhindebeskyttende virkning |
| PT2185158E (pt) * | 2007-07-31 | 2014-03-27 | Pat Gmbh | Utilização de fosfatidilcolina para tratar colite ulcerosa dependente de esteróides e refractária a esteróides |
| CN102633832B (zh) * | 2011-02-09 | 2015-07-22 | 北京绿色金可生物技术股份有限公司 | 一种制备高纯度磷脂酰胆碱的方法 |
-
2014
- 2014-03-25 EP EP14713808.5A patent/EP2978416B1/en not_active Not-in-force
- 2014-03-25 US US14/779,418 patent/US20160045523A1/en not_active Abandoned
- 2014-03-25 SG SG11201507777TA patent/SG11201507777TA/en unknown
- 2014-03-25 CN CN201480017688.2A patent/CN105377247B/zh not_active Expired - Fee Related
- 2014-03-25 BR BR112015023849A patent/BR112015023849A2/pt not_active Application Discontinuation
- 2014-03-25 PE PE2015002052A patent/PE20160037A1/es not_active Application Discontinuation
- 2014-03-25 EA EA201591510A patent/EA029514B1/ru not_active IP Right Cessation
- 2014-03-25 AU AU2014243102A patent/AU2014243102B2/en not_active Ceased
- 2014-03-25 DK DK14713808.5T patent/DK2978416T3/en active
- 2014-03-25 MD MDA20150089A patent/MD20150089A2/ro not_active Application Discontinuation
- 2014-03-25 CA CA2907401A patent/CA2907401A1/en not_active Abandoned
- 2014-03-25 UA UAA201509138A patent/UA115585C2/uk unknown
- 2014-03-25 KR KR1020157029385A patent/KR20150132841A/ko not_active Application Discontinuation
- 2014-03-25 HU HUE14713808A patent/HUE030707T2/en unknown
- 2014-03-25 JP JP2016504634A patent/JP6262843B2/ja not_active Expired - Fee Related
- 2014-03-25 MX MX2015013511A patent/MX2015013511A/es unknown
- 2014-03-25 PT PT147138085T patent/PT2978416T/pt unknown
- 2014-03-25 ES ES14713808.5T patent/ES2605650T3/es active Active
- 2014-03-25 WO PCT/EP2014/055947 patent/WO2014154683A1/en active Application Filing
- 2014-03-25 PL PL14713808T patent/PL2978416T3/pl unknown
- 2014-03-25 LT LTEP14713808.5T patent/LT2978416T/lt unknown
-
2015
- 2015-09-01 IL IL241019A patent/IL241019A0/en unknown
- 2015-09-21 PH PH12015502199A patent/PH12015502199A1/en unknown
- 2015-09-22 CL CL2015002832A patent/CL2015002832A1/es unknown
- 2015-10-23 ZA ZA2015/07910A patent/ZA201507910B/en unknown
-
2016
- 2016-05-04 HK HK16105070.4A patent/HK1217089A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2907401A1 (en) | 2014-10-02 |
| EP2978416A1 (en) | 2016-02-03 |
| JP2016516087A (ja) | 2016-06-02 |
| IL241019A0 (en) | 2015-11-30 |
| PE20160037A1 (es) | 2016-02-04 |
| CN105377247A (zh) | 2016-03-02 |
| MD20150089A2 (ro) | 2016-03-31 |
| AU2014243102B2 (en) | 2018-04-26 |
| MX2015013511A (es) | 2016-06-28 |
| HK1217089A1 (zh) | 2016-12-23 |
| BR112015023849A2 (pt) | 2017-07-18 |
| US20160045523A1 (en) | 2016-02-18 |
| PT2978416T (pt) | 2016-12-09 |
| HUE030707T2 (en) | 2017-05-29 |
| EA029514B1 (ru) | 2018-04-30 |
| EA201591510A1 (ru) | 2016-01-29 |
| UA115585C2 (uk) | 2017-11-27 |
| AU2014243102A1 (en) | 2015-09-17 |
| CL2015002832A1 (es) | 2016-03-11 |
| ZA201507910B (en) | 2017-04-26 |
| EP2978416B1 (en) | 2016-10-26 |
| DK2978416T3 (en) | 2016-12-19 |
| LT2978416T (lt) | 2016-12-12 |
| CN105377247B (zh) | 2019-04-26 |
| WO2014154683A1 (en) | 2014-10-02 |
| ES2605650T3 (es) | 2017-03-15 |
| PH12015502199A1 (en) | 2016-01-25 |
| SG11201507777TA (en) | 2015-10-29 |
| KR20150132841A (ko) | 2015-11-26 |
| JP6262843B2 (ja) | 2018-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1217089A1 (zh) | 用於治療潰瘍性結腸炎含磷脂酰胆碱的藥物製劑 | |
| HK1208378A1 (en) | Pharmaceutical composition for the treatment of fungal infections | |
| HUE045947T2 (hu) | Formuláció IBS kezelésére | |
| ZA201604225B (en) | Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus | |
| IL253177A0 (en) | Pharmacy preparation | |
| ME02981B (me) | Postupak za pripremanje ksantohumola | |
| HK1245653A1 (zh) | 藥物製劑 | |
| EP2968195A4 (en) | PHARMACEUTICAL FORMULATION WITH GLYCOSAMINOGLYCAN | |
| ZA201508452B (en) | Oral formulation for the treatment of cardiovascular diseases | |
| HK1204916A1 (en) | Pharmaceutical application of anhydroicaritin | |
| PT3340975T (pt) | Formulação para o tratamento de acne | |
| GB201511246D0 (en) | Pharmaceutical formulation | |
| EP2964257A4 (en) | TRANSCUTANEOUS DOSE FORMULATION | |
| HK1212587A1 (zh) | 用於預防或者治療糖尿病的製劑 | |
| IL244316A0 (en) | A new composition of a drug | |
| GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis |